Adam R. Kalbermatten - 17 Mar 2026 Form 4 Insider Report for KORU Medical Systems, Inc. (KRMD)

Reporting relationship: President-Chief Commercial Off
Issuer ticker: KRMD
Reported as of: 17 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Mar 2026, 16:52:45 UTC
Prior SEC filing: 11 Aug 2025
Next SEC filing: 15 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Thomas Adams - Attorney-in-Fact

Key filing fact

Adam R. Kalbermatten filed Form 4 for KORU Medical Systems, Inc. (KRMD) on 18 Mar 2026.

Key facts

This page summarizes Adam R. Kalbermatten's Form 4 filing for KORU Medical Systems, Inc. (KRMD).
3 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 18 Mar 2026, 16:52.

Change

Previous filing in this sequence was filed on 11 Aug 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002080271 Primary reporting owner

KALBERMATTEN ADAM R

Relationship: President-Chief Commercial Off
Address: C/O KORU MEDICAL SYSTEMS, INC., 100 CORPORATE DRIVE, MAHWAH
Signature: /s/ Thomas Adams - Attorney-in-Fact
Signature date: 18 Mar 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KRMD transaction Derivative

Restricted Stock Unit

Award

Transaction value
Shares: +45,098
Change %
Price: $0.000000^*
Shares after: 45,098
Date: 17 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 45,098
Exercise price
Footnotes: F1, F2

KRMD transaction Derivative

Performance Stock Unit

Award

Transaction value
Shares: +45,098
Change %
Price: $0.000000^*
Shares after: 45,098
Date: 17 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 45,098
Exercise price
Footnotes: F1, F3

KRMD transaction Derivative

Option to buy Common Stock

Award

Transaction value
Shares: +67,779
Change %
Price: $0.000000^*
Shares after: 67,779
Date: 17 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 67,779
Exercise price: $4.35
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each unit represents a right to receive one share of common stock underlying the vested award on the applicable vesting date.

Footnote F2

The units comprising the award vest in equal increments on March 17, 2027 and each first, second and third anniversaries thereof (each, a vesting date).

Footnote F3

These units will vest based upon the achievement of certain performance conditions as of December 31, 2028. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved. These units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2028.

SEC remarks

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.